The Serine Protease EspC from Enteropathogenic Escherichia coli Regulates Pore Formation and Cytotoxicity Mediated by the Type III Secretion System
RESEARCH ARTICLE
The Serine Protease EspC from
Enteropathogenic Escherichia coli Regulates
Pore Formation and Cytotoxicity Mediated
by the Type III Secretion System
Julie Guignot1,2,3,4, Audrey Segura1,2,3,4, Guy Tran Van Nhieu1,2,3,4*
1 Equipe Communication Intercellulaire et Infections Microbiennes, Centre de Recherche Interdisciplinaire
en Biologie (CIRB), Collège de France, Paris, France, 2 Institut National de la Santé et de la Recherche
Médicale U1050, Paris, France, 3 Centre National de la Recherche Scientifique UMR7241, Paris, France,
4 MEMOLIFE Laboratory of Excellence and Paris Science Lettre, Paris, France
*
Abstract
OPEN ACCESS
Citation: Guignot J, Segura A, Tran Van Nhieu G
(2015) The Serine Protease EspC from
Enteropathogenic Escherichia coli Regulates Pore
Formation and Cytotoxicity Mediated by the Type III
Secretion System. PLoS Pathog 11(7): e1005013.
doi:10.1371/journal.ppat.1005013
Editor: Tomoko Kubori, Osaka University, JAPAN
Received: February 16, 2015
Accepted: June 8, 2015
Published: July 1, 2015
Copyright: © 2015 Guignot et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information files.
Funding: This work was supported by grants from
the Inserm, the CNRS, the Collège de France and the
LABEX MEMOLIFE Laboratory of Excellence and
Paris Sciences et Lettres, Paris 75005. The funders
had no role in study design, data collection and
analysis, decision to publish, or preparation of the
manuscript.
Type III secretion systems (T3SSs) are specialized macromolecular machines critical for
bacterial virulence, and allowing the injection of bacterial effectors into host cells. The
T3SS-dependent injection process requires the prior insertion of a protein complex, the
translocon, into host cell membranes consisting of two-T3SS hydrophobic proteins, associated with pore-forming activity. In all described T3SS to date, a hydrophilic protein connects
one hydrophobic component to the T3SS needle, presumably insuring the continuum
between the hollow needle and the translocon. In the case of Enteropathogenic Escherichia
coli (EPEC), the hydrophilic component EspA polymerizes into a filament connecting the
T3SS needle to the translocon composed of the EspB and EspD hydrophobic proteins.
Here, we identify EspA and EspD as targets of EspC, a serine protease autotransporter of
Enterobacteriaceae (SPATE). We found that in vitro, EspC preferentially targets EspA
associated with EspD, but was less efficient at proteolyzing EspA alone. Consistently, we
found that EspC did not regulate EspA filaments at the surface of primed bacteria that was
devoid of EspD, but controlled the levels of EspD and EspA secreted in vitro or upon cell
contact. While still proficient for T3SS-mediated injection of bacterial effectors and cytoskeletal reorganization, an espC mutant showed increased levels of cell-associated EspA and
EspD, as well as increased pore formation activity associated with cytotoxicity. EspP from
enterohaemorrhagic E. coli (EHEC) also targeted translocator components and its activity
was interchangeable with that of EspC, suggesting a common and important function of
these SPATEs. These findings reveal a novel regulatory mechanism of T3SS-mediated
pore formation and cytotoxicity control during EPEC/EHEC infection.
Competing Interests: The authors have declared
that no competing interests exist.
PLOS Pathogens | DOI:10.1371/journal.ppat.1005013 July 1, 2015
1 / 23
EspC Regulates Type III Secretion Induced Pores
Author Summary
Enteropathogenic Escherichia coli (EPEC) is an important diarrheal pathogen responsible
for infant diarrhoea associated with significant morbidity and mortality rates in developing countries. Upon ingestion EPEC colonizes the intestinal mucosa, causing characteristic
lesions on enterocytes. Using a type III secretion system (T3SS) acting as a molecular
syringe, EPEC injects numerous bacterial proteins into host cells that disrupt the intestinal
epithelium homeostasis. Injection of T3SS proteins requires the insertion into the host cell
plasma membrane of bacterial protein complex, called the "translocon", associated with
pore-forming activity. In addition to the T3SS, EPEC also secretes other bacterial toxins
involved in virulence. Among these, the EspC is a protease reported to degrade various
host proteins. In this paper, we have characterized an "unsuspected role" for EspC. We
show that EspC degrades the T3SS translocon components following cell contact and regulates T3SS-dependent pore formation in epithelial cells. The EspC control of pore formation limits cytotoxicity and thus, is expected to limit the emission of danger signals, which
would otherwise favour bacterial clearance at the onset of infection. This work describes a
novel regulatory mechanism of pore formation mediated by the T3SS, that are likely to be
relevant for other extracellular pathogens.
Introduction
EPEC and EHEC are related pathogens causing severe diarrhoeal diseases. EPEC and EHEC
form Attaching and Effacing (A/E) lesions on the mucosal intestinal surface, corresponding to
the destruction of enterocyte microvilli and the intimate bacterial adherence to the host cell
plasma membrane onto an actin-rich pedestal structure [1]. A/E pathogens carry the Locus of
Enterocyte Effacement (LEE) encoding a type III secretion apparatus (T3SA) that allows the
delivery of bacterial effector proteins directly from the bacterial cytoplasm into the cytoplasm
of eukaryotic cells [2]. The translocator proteins EspA, B and D are required for the injection
of type III effectors. Upon cell contact, EspB and EspD insert into the host cell plasma membrane and associate into a pore-forming “translocon” complex. The hydrophilic translocator
protein EspA polymerizes into a hollow filamentous structure connecting the T3SA needle to
the translocon [3].
SPATEs are serine protease autotransporters that are widely spread among Enterobacteriaceae. SPATEs have been reported to cleave host proteins implicated in diverse functions [4,5].
EspC has been described to cleave focal adhesion proteins, following cellular internalization, as
well as other eukaryotic proteins such as haemoglobin, pepsin and human coagulation factor V
[5,6,7]. Epidemiological studies indicated that EspC was predominantly found in t-EPEC
strains and that EPEC strains carrying EspC and the OI-122 pathogenicity island were associated with high virulence [8,9]. These observations suggest that EspC could contribute to bacterial virulence by regulating the action of virulence factors.
Although secretion of EspC occurs through a T3SS-independent mechanism, several intriguing features link EspC and the T3SS. The expression of EspC is coupled to that of t (...truncated)